Expression of TNF and the 55‐kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma

Oral Diseases - Tập 2 Số 1 - Trang 25-31 - 1996
F Younes1, EL Quartey1, S Kiguwa1, M Partridge1
1Epithelial Cell Biology Unit, King's College School of Medicine and Dentistry. Denmark Hill, London SE5 8RX, UK

Tóm tắt

TNF has diverse biological effects including a role in the immune response and growth regulatory effects.OBJECTIVES: The aim of this study was to determine the nature and location of cells able to synthesise and respond to TNF in oral mucosa in health and disease.MATERIALS AND METHODS: The location of immuno‐reactive TNF and 55‐kDa and 7s‐kDa TNF receptors was demonstrated using immunohistology. We also used RT‐PCR to help determine the sites of synthesis of this cyto‐kine in oral mucosa.RESULTS: Only occasional TNF‐positive cells were detected in normal epidermis and oral mucosa. However, this cytokine was found throughout the epithelia in oral lichen planus, leukoplakia and squamous cell carcinoma (SCC). The possible cellular sources and biological effects of TNF in these disease processes is discussed. The 55‐kDa TNFR was expressed at the cell membrane throughout the epidermis, but confined to the lower cell layers on oral mucosa. Ten of 22 SCC did not express this receptor. A significant correlation was observed between the velocity of tumour growth and absence of TNF receptors.CONCLUSIONS: The growth inhibitory and immuno‐regulatory effects of TNF may be modulated by changes in receptor expression and alterations in synthesis of this cytokine in a subgroup of oral SCC.

Từ khóa


Tài liệu tham khảo

Anneroth G., 1987, Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas, Scand J Dent Res, 95, 229

10.1016/0923-1811(91)90019-T

Beutler BA, 1985, Cachectin/tumour necrosis factor: production, distribution, and metabolic fate in vivo, J Immunol, 135, 3972, 10.4049/jimmunol.135.6.3972

10.1073/pnas.87.8.3127

10.1073/pnas.72.9.3666

10.1084/jem.165.6.1581

10.1084/jem.162.6.2163

10.1038/316701a0

10.1056/NEJM198612253152606

10.1073/pnas.89.4.1398

Engelmann H, 1989, A tumour necrosis factor binding protein purified to homogeneity from human urine protects cells from tumour necrosis factor toxicity, J Biol Chem, 264, 11974, 10.1016/S0021-9258(18)80162-4

Fajardo LF, 1992, Dual role of tumour necrosis factor‐α. angiogenesis, Am J Pathol, 140, 539

10.1016/0014-5793(91)80803-B

10.1111/j.1600-0714.1992.tb00973.x

10.1073/pnas.84.15.5277

10.1111/j.1365-2249.1993.tb03457.x

10.1016/0014-5793(90)81127-A

Lanick JW, 1989, Activated Langerhans cells release tumour necrosis factor, J Leukocyte Biol, 45, 429, 10.1002/jlb.45.5.429

10.1016/0266-4356(92)90263-I

10.1111/1523-1747.ep12491890

10.1172/JCI113903

Nickoloff BJ, 1991, Cellular localization of interleukin‐8 and its inducer, tumour necrosis factor‐alpha in psoriasis, Am J Pathol, 138, 129

10.1111/j.1365-2133.1988.tb02430.x

10.1038/312724a0

10.1172/JCI113963

10.1016/0030-4220(85)90262-2

Ryffel B, 1991, Tumour necrosis factor receptors in lymphoid tissues and lymphomas, J Immunol, 138, 2711

Schuger L, 1989, Cytotoxicity of tumour necrosis factor‐α for human umbilical vein endothelial cells, Lab lnvest, 61, 62

10.1038/bjc.1990.78

10.1126/science.3933111

10.1111/1523-1747.ep12491668

Ulich THR, 1987, Kinetics and mechanisms of recombinant human interleukin 1 and turnour necrosis factor‐a induced changes in circulating numbers of neutrophils and lymphocytes, J Immunol, 139, 3406, 10.4049/jimmunol.139.10.3406

10.1111/j.1600-0714.1989.tb00762.x

10.1111/j.1600-0714.1990.tb00866.x

10.1073/pnas.88.10.4220